Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Study of ALK-001 on the Progression of Stargardt Disease — Stella

Home/Stargardt Disease/Study of ALK-001 on the Progression of Stargardt Disease

View on ClinicalTrials.gov

Recruiting

Back to Stargardt Disease trials

Study of ALK-001 on the Progression of Stargardt Disease

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

United States

Erie Retina Research, Erie, Pennsylvania

Key details

Phase

Large-scale testing

Sponsor

Alkeus Pharmaceuticals, Inc.

Enrollment target

~230 participants

Started

April 2026

Primary completion

October 2029

Age range

8 Years – 45 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.